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Abstract
Background: Thiamine (vitamin B1) deficiency (TD) causes mild impairment of oxidative metabolism and region-
selective neuronal loss in the central nervous system (CNS). TD in animals has been used to model aging-
associated neurodegeneration in the brain. The mechanisms of TD-induced neuron death are complex, and it is
likely multiple mechanisms interplay and contribute to the action of TD. In this study, we demonstrated that TD
significantly increased intracellular calcium concentrations [Ca
2+]i in cultured cortical neurons.
Results: TD drastically potentiated AMPA-triggered calcium influx and inhibited pre-mRNA editing of GluR2, a Ca
2
+-permeable subtype of AMPA receptors. The Ca
2+ permeability of GluR2 is regulated by RNA editing at the Q/R
site. Edited GluR2 (R) subunits form Ca
2+-impermeable channels, whereas unedited GluR2 (Q) channels are
permeable to Ca
2+ flow. TD inhibited Q/R editing of GluR2 and increased the ratio of unedited GluR2. The Q/R
editing of GluR2 is mediated by adenosine deaminase acting on RNA 2 (ADAR2). TD selectively decreased ADAR2
expression and its self-editing ability without affecting ADAR1 in cultured neurons and in the brain tissue. Over-
expression of ADAR2 reduced AMPA-mediated rise of [Ca
2+]i and protected cortical neurons against TD-induced
cytotoxicity, whereas down-regulation of ADAR2 increased AMPA-elicited Ca
2+ influx and exacerbated TD-induced
death of cortical neurons.
Conclusions: Our findings suggest that TD-induced neuronal damage may be mediated by the modulation of
ADAR2-dependent RNA Editing of GluR2.
Background
Thiamine (vitamin B1) deficiency (TD) induces chronic
mild impairment of oxidative metabolism and causes
neuroinflammation, leading to neuronal loss in specific
brain regions [1]. Experimental TD causes a reduction
of thiamine-dependent enzyme activities in multiple
brain regions which is also observed in patients with
Alzheimer’s disease (AD) [2,3]. Since TD-induced neu-
ronal damages and aging-associated neurodegeneration
share many common features, TD in animals has been
used to model the pathogenesis of aging-related
neurodegeneration in humans. A recent study shows
benfotiamine, a thiamine derivative with better bioavail-
ability than thiamine, has powerful beneficial effects on
cognitive impairment in the Morris water maze and
b- amyloid deposition in amyloid precursor protein/pre-
senilin-1 transgenic mice [4]. The TD in humans causes
Wernicke-Korsakoff syndrome (WKS), which is charac-
terized by severe memory loss, cholinergic deficits and
selective cell death in specific brain regions [1,5-7]. The
causes for TD-induced neuronal damage remain unclear.
Several potential mechanisms have been proposed; these
include mitochondrial dysfunction [8,9], impairment of
oxidative metabolism [10,11] and acidosis [12,13]. We
have recently demonstrated that TD causes endoplasmic
reticulum (ER) stress in neurons, and ER stress may
contribute to TD-induced neuronal damage [14]. ER
stress is caused by the accumulation of unfolded
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the inhibition of protein glycosylation and the perturba-
tion of calcium homeostasis [15-17].
In the late stage of TD, an increase in extracellular
glutamate is observed in some brain regions [6,18]. The
s e l e c t i v ev u l n e r a b i l i t yt oT Dm a yb em e d i a t e db yag l u -
tamate-induced excitotoxic process in affected struc-
tures, leading to alterations in membrane potential and
disturbances in calcium homeostasis [19,20]. Calcium
ions (Ca
2+) can enter neurons through several mechan-
isms. One important mechanism is through the activa-
tion of glutamate receptors [21]. There are three types
of ionotropic glutamate receptors: N-methyl-d-aspartate
receptors (NMDARs), alpha-amino-3-hydroxyl-5-
methyl-4- isoxazole-propionic acid receptors (AMPARs)
and kainate receptors (KRs), each having several sub-
types. The current study focuses on AMPARs. In the
mammalian central nervous system (CNS), AMPARs are
widely expressed both in neurons and in glia and med-
iate the vast majority of fast excitatory synaptic trans-
mission [22,23]. AMPARs are tetramers made up of
combinations of four subunits: GluR1, GluR2, GluR3
and GluR4 (also called ‘’GluRA-D’’) [24,25].
The Ca
2+ permeability of AMPAR channels is deter-
mined by the GluR2 subunit [26-28]. The property of
GluR2 is altered by pre-mRNA editing. This post-tran-
scriptional modification involves the enzymatic deami-
nation of a specific adenosine in the pre-mRNA prior to
splicing [29]. The adenosine deamination results in the
substitution of glutamine (Q) with arginine (R) in the
membrane domain M2 of the receptor channel. The edi-
ted GluR2 (R) subunits form Ca
2+-impermeable chan-
nels, whereas unedited GluR2 (Q) channels are
permeable to Ca
2+ flow [29].
Enzymes responsible for RNA editing are termed “ade-
nosine deaminases acting on RNA” (ADARs), and three
structurally related ADARs (ADAR1 to ADAR3) have
been identified in mammals [30-32]. ADAR1 and ADAR2
are widely detected in various tissues, with strong expres-
sion in the brain [30,33]. ADAR2 predominantly catalyzes
RNA editing at the Q/R sites of GluR2 both in vitro and in
vivo [34], whereas both ADAR1 and ADAR2 catalyze the
Q/R sites of GluR5 and GluR6 subunits of kainite recep-
tors. ADAR3 is detected only in the brain, but its deami-
nating activity has not been demonstrated [31,32]. ADAR2
pre-mRNA and mRNA themselves are susceptible to A-
to-I editing mediated by ADAR2 [35]. The objective of the
present study is to investigate the effect of TD on
AMPAR-mediated Ca
2+ influx and GluR2 RNA editing.
Our results show that TD down-regulates the expression
of ADAR2 and inhibits GluR2 pre-mRNA editing at the
Q/R site, resulting in increased Ca
2+ permeability. TD-
induced disruption of Ca
2+ homeostasis may at least par-
tially contribute to its neurotoxicity.
Results
Effects of thiamine deficiency (TD) on intracellular calcium
concentration
TD was induced in cortical neurons of DIV7 for one or
four days as previously described [36]. Intracellular free
calcium [Ca2
+]i was measured using the fluorescent Ca
2
+ chelator Fura-2. As shown in Figure 1A, four days of
TD (TD4) caused a significant increase in resting [Ca
2+]
i;[ C a
2+]i was approximately 200 nM and 900 nM in
control and TD cultures, respectively, suggesting that
TD increased the influx of Ca
2+. Since AMPARs are
important mediators of Ca
2+ influx, we sought to deter-
mine whether TD affected AMPA-elicited Ca
2+ influx.
Cells were incubated with a low-affinity fluorescent Ca
2+
probe Fluo-3 and challenged with a brief pulse (5 sec)
of AMPA (30 μM). More than 95% of the monitored
cells responded to AMPA stimulation and TD4
increased Fluo-3 fluorescence intensity (Figure 1B).
The analysis of Fluo-3 fluorescence imaging on a sin-
gle cell indicated that AMPA-induced Ca
2+ influx
peaked at 3-10 sec and returned to basal levels within 2
min (Figure 1C). To verify AMPA-induced Ca
2+ influx
was mediated by AMPA receptors, after an initial
AMPA pulse, neurons were exposed to a second AMPA
pulse in the presence of a general AMPA receptor
antagonist, GYKI. The AMPA-induced increase in [Ca
2
+]i was inhibited by GYKI, indicating the currents were
mediated by AMPARs (Figure 1C). The specificity of
AMPA-mediated response was further supported by the
perfusion of GABAA receptor antagonist bicuculline
plus Na
+ channel blocker tetrodotoxin which failed to
block AMPA-increased [Ca
2+]i (Figure 1E). Furthermore,
the use of a calcium-free buffer eliminated an AMPA-
triggered rise in [Ca
2+]i, indicating the calcium response
is dependent on extracellular Ca
2+ (data not shown).
Thus, AMPA-mediated calcium elevations in cultured
cells are primarily through Ca
2+-permeable AMPARs.
More importantly, TD4 drastically potentiated AMPA-
elicited Ca
2+ influx (Figure 1C and 1D).
TD inhibits GluR2 RNA editing in cortical neurons
We sought to determine the mechanisms underlying
TD-mediated alteration of Ca
2+-permeable AMPARs.
The GluR2 subtype of AMPARs regulates Ca
2+-perme-
ability. The immunocytochemical studies indicated that
GluR2 was widely expressed in cultured cortical neurons
(Figure 2A). TD did not alter either the protein or
mRNA levels of GluR2 (Figure 2B and 2C). Since the
glutamine/arginine (Q/R) site editing of GluR2 pre-
mRNA controls the Ca
2+ permeability of AMPAR com-
plexes, we investigated the effect of TD on Q/R site
editing. Direct sequencing of the RT-PCR products
demonstrated that there was a Q/R site editing of
GluR2 mRNA in cultured cortical neurons (Figure 3A).
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Page 2 of 13Figure 1 The effect of TD on AMPA-stimulated [Ca
2+]i in cultured cortical neurons. A: Cortical neurons were maintained in vitro for 7 days
(DIV7), and TD was induced by the treatment of amprolium (1 mmol/L) for 1 or 4 days (TD1 or TD4). The resting [Ca
2+]i was measured as
described under the Materials and Methods. B: Cortical neurons of DIV7 were treated with amprolium (0 or 1 mmol/L) for 4 days and perfused
with AMPA (30 μM) for 5 sec. The calcium image (Fluo-3 fluorescence) was recorded as described under the Material and Methods. There were
240 cells for each treatment group. Scale bar = 20 μm. The colored scale bar indicates the fluorescence intensity of Fluo-3. C: Cortical neurons of
DIV7 were treated with amprolium (0 or 1 mmol/L) for 1 or 4 days and then perfused with AMPA (30 μM) for 5 seconds. Two minutes after the
first AMPA perfusion, neurons were subjected to a second AMPA perfusion with/without a general AMPAR antagonist GYKI (30 μM). Intracellular
free levels [Ca
2+]i were determined by single cell Fluo-3 fluorescence imaging. The data show a representative response to AMPA by a single
cell. D: The intensity of Fluo-3 fluorescence was quantified as described under the Materials and Methods. The results were calculated based on
75 cells. E: Cortical neurons of DIV7 were treated with amprolium (1 mmol/L) for 4 days and perfused with AMPA (30 μM) for 5 sec, followed by
a second perfusion with AMPA plus tetrodotoxin (TTX; 0.5 μM)/bicuculline (BIC; 10 μM). A third AMPA perfusion was performed in the presence
of AMPAR antagonist GKKI (30 μM). The perfusions were 2 min apart. The results were expressed as the mean ± SEM. *p < 0.001. The
experiments were replicated three times.
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ing the percentage of edited products. TD significantly
decreased the efficiency of Q/R editing (Figure 3B).
TD decreases ADAR2 expression and activity
The Q/R editing of GluR2 is mediated by ADAR2
[37,38]. The decrease in RNA editing at Q/R sites sug-
gests that TD may inhibit ADAR2 activity or expression.
We examined the effect of TD on the expression of
A D A R 2a sw e l la sA D A R 2s e l f -editing activity in cul-
tured cortical neurons. Immunoblotting analysis indi-
cated that TD significantly decreased the expression of
ADAR2, but not ADAR1 in cortical neurons (Figure 4A
and 4B). A real-time PCR study showed that TD down-
regulated mRNA levels of ADAR2, but not that of
ADAR1 in cortical neurons (Figure 4E). Furthermore,
TD in C57BL/6J mice also selectively reduced both
mRNA and protein levels of ADAR2, but not that of
ADAR1 (Figure 4C, 4D and 4F).
The self-editing of ADAR2 pre-mRNA has been used
to evaluate ADAR2 activity [39]. A to I editing by
ADAR2 within intron 4 creates an AI (= AG) 3’ splice
site that leads to alternatively spliced mRNA with a 47-
nucleotide (nt) insert [40]. We examined the effect of
TD on ADAR2 self-editing-dependent alternative spli-
cing. As shown in Figure 5 TD significantly reduced the
percentage of alternatively spliced products (+47 nt),
indicating a decreased ADAR2 self-editing activity.
Manipulation of ADAR2 expression alters AMPA-mediated
Ca
2+ influx and TD-induced cytoxicity
To further determine the role of ADAR2 in AMPA-
mediated Ca
2+ influx and TD-induced cytoxicity, we
manipulated the expression of ADAR2 in cortical neu-
rons. We increased ADAR2 expression in cortical
Figure 2 The expression of GluR2 AMPA receptor in cultured
cortical neurons. A: The expression of GluR2 in cortical neurons of
DIV7 was examined by immunofluorescence analysis (right panel).
The DIC image was shown for comparison (left panel). B: Cortical
neurons were treated with amprolium (Amp, 0 or 1 mmol/L) for 1
or 4 days. The expression of GluR2 was examined by
immunoblotting analysis. The expression of a-tubulin served as a
loading control. C: The mRNA levels of GluR2 were determined by
RT-PCR. The expression of b-actin mRNA served as an internal
control. The experiments were replicated three times.
Figure 3 Effects of TD on the editing efficiency of GluR2
mRNA. A: Cortical neurons were treated with amprolium (Amp, 0
or 1 mmol/L) for 1 or 4 days (TD1 or TD4). Total RNA was isolated
and PCR products of GluR2 were sequenced as described under the
Materials and Methods. Sequence chromatograms of GluR2
transcripts were presented. Q/R indicates the glutamine/arginine
editing position. The ratio of G (black) to A (green) reflects the
editing efficiency. B: The Q/R site editing efficiency was calculated.
The results were expressed as the mean ± SEM. *p <0.001. The
experiments were replicated three times.
Lee et al. Molecular Neurodegeneration 2010, 5:54
http://www.molecularneurodegeneration.com/content/5/1/54
Page 4 of 13neurons by transfecting cells with a wild type ADAR2
cDNA, and decreased its expression by treating it with a
short hairpin RNA (shRNA) of ADAR2. As shown in
Figure 6 transfection of ADAR2 cDNA effectively
increased ADAR2 expression, whereas shADAR2
decreased ADAR2 expression in cortical neurons. Over-
expression of ADAR2 significantly inhibited an AMPA-
mediated rise of [Ca
2+]i in cortical neurons; contrarily,
down-regulation of ADAR2 enhanced AMPA-mediated
Ca
2+ influx, indicating the manipulation of ADAR2
expression was sufficient to alter Ca
2+ permeability of
AMPARs channels (Figure 7). We further determined
the role of ADAR2 in TD-induced neurotoxicity. As
s h o w ni nF i g u r e8o v e r - e x p ression of ADAR2 signifi-
cantly ameliorated TD-induced death of cortical neu-
rons; while down-regulation of ADAR2 enhanced
Figure 4 The expression of ADAR2 in cultured cortical neurons. A: Cortical neurons were treated with amprolium (Amp, 0 or 1 mmol/L) for
1, 3 or 5 days. The expression of ADAR1 and ADAR2 was examined by immunoblotting analysis. The expression of a-tubulin served as a loading
control. B: The relative amounts of ADAR1 or ADAR2 protein were measured microdensitometrically and normalized to the expression of a-
tubulin. C: TD was induced in mice as described under the Materials and Methods. At specified times after TD, the brain was removed (n = 5 for
each treatment group). The expression of ADAR1 and ADAR2 was determined by immunoblotting analysis. D: The relative amounts of ADAR1
and ADAR2 protein in the brain were measured microdensitometrically and normalized to the expression of a-tubulin. E: Cortical neurons were
treated with amprolium (Amp, 0 or 1 mmol/L) for 1, 3 or 5 days. The relative mRNA levels of ADAR1 and ADAR2 were quantified with real time
PCR as described under the Materials and Methods. F: TD was induced in mice as described above. At specified times after TD, the brain was
removed (n = 5 for each group). The relative mRNA levels of ADAR1 and ADAR2 were quantified with real time PCR. The results were expressed
as the mean ± SEM. *p < 0.05. The experiments were replicated three times.
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s u g g e s tt h a tA D A R 2m a yb ei n v o l v e di nT D - i n d u c e d
death of cortical neurons.
Discussion
In this study, we demonstrate for the first time that TD
drastically increases [Ca
2+]i in cortical neurons. The
effect of TD is duration-dependent; TD treatment for 1
day (TD1) does not significantly alter [Ca
2+]i whereas
TD4 raises [Ca
2+]i from approximately 200 nM to 900
nM. Consistent with the profile of alterations in [Ca
2+]i,
TD4, but not TD1, induces the death of cortical neu-
rons (data not shown). The close correlation suggests an
association between Ca
2+ influx and TD neurotoxicity.
Further studies are necessary to confirm that TD-
induced neurotoxicity is caused by the rise of [Ca
2+]i.
Ca
2+ ions are necessary for proper function and survival
of neurons. Ca
2+ is a key regulator of synaptic plasticity.
However in many pathological states, [Ca
2+]i reaches
critical levels leading to cell injury or death [21]. Ca
2+
overload can trigger several downstream lethal reactions,
including nitrosative stress, oxidative stress, endoplasmic
reticulum (ER) stress and mitochondrial dysfunction
[15-17,41]. Ca
2+ i sk n o w nt op l a yac e n t r a lr o l ei n
excitotoxicity [42].
We have previously demonstrated that TD induces ER
stress in animals and in cultured neurons [14]. ER stress
refers to the accumulation of unfolded or misfolded pro-
teins in the ER lumen, resulting in an overall decrease in
translation, enhanced protein degradation and increased
levels of ER chaperones, which consequently increase
the protein folding capacity of the ER. Sustained ER
stress ultimately leads to the apoptotic death of the cell
[43,44]. A major cause of ER stress is the perturbation
of calcium homeostasis [15-17]. Thiamine selectively
diminished the reactive nitrogen species (RNS) and
capacitative calcium entry (CCE) in the endoplasmic
reticulum of fibroblasts [45]. Therefore, it is likely that
TD-induced ER stress in neurons results from altera-
tions in [Ca
2+]i.
Ca
2+ levels are increased in aging neurons and the
dysregulation of [Ca
2+]i is implicated in neurodegenera-
tion that occurs in AD [42]. b-amyloid protein (Ab) sti-
mulates Ca
2+ influx and raises [Ca
2+]i in neurons,
resulting in neuronal death [42]. TD in animals has
been used to model some pathogenesis processes of AD.
The current findings reveal that dysregulation of Ca
2+
may be another common feature for TD-mediated
Figure 5 Effects of TD on ADAR2 self-editing activity in
cultured cortical neurons. A: Cortical neurons were treated with
amprolium (Amp, 0 or 1 mmol/L) for 1 or 4 days (TD1 or TD4). The
expression of ADAR2 mRNA was analyzed by RT-PCR as described
under the Materials and Methods. The products of alternative
splicing of ADAR2 mRNA (+ 47 nt) were examined. B: The self-
editing efficiency of ADAR2 mRNA was quantified by calculating the
percentage of alternative splicing products (+47 nt). The results
were expressed as the mean ± SEM. *p < 0.05. The experiments
were replicated three times.
Figure 6 The transfection of ADAR2 cDNA and shADAR2 RNA
in cultured cortical neurons. A. Cortical neurons were transfected
with empty vector pcDNA6, pcDNA6 carrying wild-type ADAR2
cDNA, scramble short hairpin RNA (shCon) and shRNA for ADAR2
(shADAR2) along with a YFP construct for two days as described
under the Materials and Methods. The expression of ADAR2 was
determined by immunoblotting analysis. B: The expression of
ADAR2 was quantified microdensitometrically and normalized to the
expression of a-tubulin. The results were expressed as the mean ±
SEM of three independent assays. *p < 0.05.
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AD.
Ca
2+ can gain entry into neurons through several
mechanisms. Since TD increases glutamate levels in the
brain, we investigate the effect of TD on glutamate
receptor-regulated Ca
2+ influx. Our results indicate that
TD drastically potentiates AMPA-mediated Ca
2+ influx.
A recent study shows that Ca
2+-permeable AMPARs are
induced by in vitro traumatic mechanical injury in
cortical neurons which results in increased [Ca
2+]i [46].
A TD-induced increase in [Ca
2+]i m a yb ec a u s e db yt h e
dysregulation of Ca
2+ -permeable AMPARs. GluR2 is a
critical subunit in determining many of the major bio-
physical properties of AMPAR s ,i n c l u d i n g ,b u tn o tl i m -
ited to, Ca
2+ permeability, receptor kinetics, single-
channel conductance and blockage by endogenous poly-
amines [47]. The great majority of AMPARs in the CNS
exist as heteromers containing GluR2. AMPARs lacking
Figure 7 Effects of ADAR2 over-expression or ADAR2 knock-down on AMPA-triggered [Ca2+]i. A: Cortical neurons were transfected with
empty vector pcDNA6, pcDNA6 carrying wild-type ADAR2 cDNA, scrambled short hairpin RNA (shCon) and shRNA for ADAR2 (shADAR2) along
with a YFP construct for two days. After that, neurons were perfused with AMPA (30 μM) for 5 seconds. Two minutes after the first AMPA
perfusion, neurons were subjected to a second AMPA perfusion with/without a general AMPAR antagonist GYKI (30 μM). [Ca
2+]i was determined
by single cells Fluo-3 fluorescence imaging as described under the Materials and Methods. B: The intensity of Fluo-3 fluorescence was quantified
as described under the Materials and Methods. The results were calculated based on 75 cells. The results were the mean ± SEM from three
independent assays. *p < 0.05.
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2+ and Zn
2+.C a
2+ permea-
tion through AMPARs is crucial in several forms of
synaptic plasticity and cell death associated with neuro-
logical diseases and disorders. The subunit composition
and Ca
2+ permeability of AMPARs are not static, but
they are dynamically remodeled in a cell- and synapse-
specific manner during development and in response to
neuronal activity. The subunit composition and perme-
ability of AMPARs are also remodeled by neuronal
insults, such as seizures, ischemia, excitotoxicity, spinal
cord injury and neurological diseases [e.g. AD, amyo-
trophic lateral sclerosis (ALS)] [48].
The changes in GluR2 properties may serve as a
‘molecular switch’ leading to the formation of Ca
2
Figure 8 Effects of ADAR2 over-expression or ADAR2 knock-down on TD-induced death of cortical neurons. A: Cortical neurons were
transfected with wild-type ADAR2 construct or pcDNA6 vector along with YFP construct and treated with amprolium (Amp, 0 or 1 mmol/L) for
4 days. The cytotoxicity was determined by propidium iodide (PI) staining (top panel). The percentage of PI-positive neurons in culture treated
with wild-type ADAR2 or pcDNA6 was quantified (bottom panel). The results were expressed as the mean ± SEM of three independent assays. *
signifies statistical differences from the controls (p < 0.05). # signifies statistical differences from the cultures treated with TD and pcDNA6 (p <
0.05). B: Cortical neurons were transfected with shADAR2 or shCON and treated with amprolium (Amp, 0 or 1 mmol/L) for 4 days. The
cytotoxicity was determined by PI staining (top panel). The percentage of PI-positive cells in cultures treated with shADAR2 or shCON was
quantified (bottom). The results were expressed as the mean ± SEM of three independent assays. * signifies statistical differences from the
controls (p < 0.05). # signifies statistical differences from the cultures treated with TD and shCON (p < 0.05).
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neurological insults [49]. These changes arise not only
from dysregulation of the expression of GluR2, but also
because of RNA editing [50] and receptor trafficking
[51]. Abnormal editing of GluR2 pre-mRNA at the Q/R
site has been demonstrated to be associated with certain
neurological insults such as ALS and brain ischemia
[41,52]. A recent study indicates that inhibiting RNA
editing of GluR2 at the Q/R site enhances the death of
motor neurons through excitoxicity, whereas enhanced
RNA editing reduces calcium permeability and protects
motor neurons [52]. Furthermore, the expression of
AMPARs with unedited GluR2 is highly toxic in cul-
tured hippocampal neurons [53]. Interestingly, RNA
editing at the Q/R site of GluR2 is involved in neuronal
differentiation [29,54], supporting the notion that there
is a physiological role of GluR2 RNA editing in the CNS
development.
We demonstrate that TD does not affect GluR2
expression, but inhibits its RNA editing. The profile of
TD-induced inhibition of GluR2 RNA editing is consis-
tent with TD’se f f e c to nC a
2+ influx; TD1 induces a
modest inhibition of RNA editing, while TD4 produces
much more inhibition (Figure 3). Therefore, TD
increases the ratio of unedited GluR2 which is perme-
able to Ca
2+.
The pre-mRNA editing of GluR2 at the Q/R site is
regulated by a nuclear enzyme, ADAR2. ADAR2 knock-
out mice are fatal, indicating ADAR2 plays an essential
role for survival [37]. Interestingly, TD selectively down-
regulates ADAR2 expression without affecting ADAR1
in vitro and in vivo, indicating some specificity of TD’s
action. It has been shown that NF-B regulates the
expression of ADAR2 [55]and TD inhibits the transcrip-
tion activity of NF-B and AP-1 in neuronal cells [56].
Therefore, it is likely that TD down-regulates ADAR2
by modulating the activity of transcription factors. Gen-
erally, the pattern of TD-induced inhibition of ADAR2
expression is consistent with that of its interference with
GluR2 RNA editing, i.e., longer TD exposure causes
more inhibition. TD-induced down-regulation of
ADAR2 is accompanied with a decrease in ADAR2 tran-
scripts, suggesting that TD may affect either the tran-
scription or mRNA stability of ADAR2. TD also inhibits
ADAR2 self-editing which is indicated by a significant
decrease in alternatively spliced products (+47 nt), sug-
gesting that TD may also interfere with ADAR2 enzy-
matic activity.
Conclusions
The contribution of ADAR2 in AMPA-mediated Ca
2+
influx in cortical neurons is confirmed by experiments
that manipulate the expression levels of ADAR2 in cor-
tical neurons. Over-expression of ADAR2 inhibits
AMPA-mediated Ca
2+ influx, while knocking-down
ADAR2 enhances AMPA-mediated Ca
2+ influx. In par-
allel, high expression of ADAR2 offers neuroprotection
against TD-induced cytotoxicity, whereas down-regula-
tion of ADAR2 exacerbated TD-induced death of corti-
cal neurons. Similar to our finding, Peng et al., (2006)
[41] show that forebrain ischemia in adult rats selec-
tively reduces the expression of ADAR2 and disrupts
RNA Q/R site editing of GluR2 in vulnerable neurons.
Expression of exogenous ADAR2 or induction of endo-
genous ADAR2 expression protects neurons from fore-
brain ischemia insult [41]. Taken together, these results
suggest TD-mediated inhibition of ADAR2 expression/
activity causes a disruption of GluR2 RNA editing,
resulting in increased Ca
2+ influx and elevated [Ca
2+]i.
Thus, ADAR2-dependent GluR2 Q/R site editing may
determine vulnerability of neurons to TD.
Material and methods
Materials
Fura-2 was obtained from Invitrogen (Carlsbad, CA,
USA). Fluo-3 was obtained from Calbiochem (EMD
Chemicals, Inc. Gibbstown, NJ, USA). Anti-GluR2 anti-
body was obtained from Chemicon (Temecula, Ca,
USA). Anti-ADAR2 and ADAR1 antibodies were
obtained from Santa Cruz Biotech (Santa Cruz, CA,
USA). The secondary Texas Red conjugated donkey
anti-rabbit IgG for GluR2 and FITC-conjugated donkey
anti-Goat IgG for ADAR2 were obtained from Jackson
ImmunoResearch Laboratories (West Grove, PA, USA).
All other chemicals were obtained from Sigma Chemical
Co. (St. Louis, MO, USA).
Culture of cortical neurons
Primary cultures of cortical neurons were generated
using a previously described method [57,58]. Briefly, the
14 day C57BL/6J mouse embryos were decapitated and
cerebra were removed. The cerebra were minced with a
sterile razor blade and suspended in 10 ml of trypsin
solution (0.025%) at 37°C. After incubation for 15 min,
an equal volume of a solution containing DNase (130
Kunitz units/ml) and trypsin inhibitor (0.75 mg/ml) was
added, and the tissue was sedimented by a brief (5 s)
centrifugation. The tissue was dissociated by trituration,
and the cell suspension was mixed with 4% bovine
serum albumin and centrifuged. The cell pellet was
resuspended in Neurobasal/B27 medium containing 2%
B27 and 1 mmol/L glutamine (Invitrogen Corporation,
Carlsbad, CA, USA), 100 units/ml penicillin and 100 μg/
ml streptomycin (Gibco Inc.; Los Angeles, CA, USA).
Cells were plated into poly-D-lysine (50 μg/ml) coated
cell culture wells or dishes, and maintained at 37°C in a
humidified environment containing 5% CO2 for 7 days
in vitro (DIV7).
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To induce TD in vitro, cortical neurons of DIV7 were
treated with amprolium (1 mmol/L) for indicated times
[8,14,36]. Amprolium is a competitive inhibitor of thia-
mine transport and effectively depletes intracellular thia-
mine. The animal TD model has been previously
described [1]. Briefly, adult male C57BL/6J mice (20-25
g) were housed in a controlled environment (one
mouse/cage at 23°C and 53% humidity). The animals
were fed with either a control diet or a thiamine defi-
cient diet (ICN Nutrition Biomedicals, Cleveland, OH,
USA) ad libitum. TD animals also received a daily i.p.
injection of a thiamine antagonist, pyrithiamine hydro-
bromide (5 μg/10 g body weight), while control animals
were injected with saline. Pyrithiamine is a potent inhi-
bitor of thiamine pyrophosphokinase and blocks the
synthesis of thiamine diphosphate (TDP).
Measurement of propidium iodide (PI) uptake
Cytotoxicity was analyzed by propidium iodide (PI)
uptake. Neuronal cultures were incubated with PI (20
μg/ml) for 15 min. The fluorescence signals were
detected by a Zeiss LSM 510 confocal system (Carl
Zeiss MicroImaging, Inc., Thornwood, New York) on an
inverted microscope. The excitation and emission wave-
lengths were 490 and 615 nm, respectively.
Measurements of intracellular free calcium
The concentrations of intracellular free calcium [Ca
2+]i
were measured using Fura-2/acetoxymethyl ester (Fura-
2/AM) as described previously with some modifications
[59]. The measurement was performed in 96-well micro-
titer plates. Briefly, cells were incubated in Hank’ss o l u -
tion containing Fura-2/AM (5 μm) at 37°C for 45 min.
Cells were alternatively excited with 340 and 380 nm
wavelengths, and fluorescence signals were detected
with the FlexStation (Molecular Devices, Wokingham,
UK). Fluorescence ratios were converted to [Ca
2+]i by
using the equation of [Ca
2+]i = Kd*(F-Fmin)/(Fmax-F) [60]
with apparent dissociation constant Kd = 0.224 mM.
The Rmin and Rmax were determined by equilibrating
[Ca
2+]i with “calcium-free” (0 mM Ca
2+/10 mM EGTA)
or high Ca
2+(10 mM Ca
2+ in Hepes), respectively.
[Ca
2+]i levels were also quantified by single cell Fluo-3
fluorescence image as described previously [61] with
some modifications. Briefly, cells were loaded with Fluo-
3/AM (2 μM, Calbiochem) in Ringer solution at 37°C
for 45 min, then transferred to a perfusion chamber and
perfused with calcium buffer or calcium-free buffer.
Cells were perfused at 1 ml/min at room temperature
using a peristaltic pump. The calcium image was
recorded with a confocal laser scanning microscope
(Carl Zeiss Axiovert 200 LSM 510, Jena, Germany). A
field including 15-20 cells was selected. Successive
images of 512×512 pixels were collected at intervals of
1.97 s with a 40× oil-immersion objective and each ser-
ies of images consisted of 300 sections. Fluo-3 fluores-
cence was excited at 488 nm and emitted light was
measured at 530 nm. The intensity of Fluo-3 fluores-
cence intensity represented [Ca
2+]i. The quantification
of Fluo-3 fluorescence intensity was performed using
the software Rel.3.2 (Carl Zeiss MicroImaging, Inc.,
Thornwood, New York).
Immunocytochemistry
Neuronal cultures on cover slips were treated with
amprolium for indicated times and fixed with 4% paraf-
ormaldehyde. The cultures were incubated with primary
a n t i b o d i e sa t4 ° Co v e r n i g h ta tt h ef o l l o w i n gc o n c e n t r a -
tions: Anti-GluR2 antibody, 0.5 μg/ml; anti-ADAR2
antibody, 1:500. This was followed by secondary anti-
body treatment (Texas Red conjugated donkey anti-rab-
bit IgG or FITC-conjugated donkey anti-Goat IgG at a
dilution of 1:100). Fluorescent images were visualized
with a Zeiss LSM 510 confocal system (Carl Zeiss
MicroImaging, Inc., Thornwood, NY) using a 40× oil-
immersion objective lens. Differential interference con-
trast (DIC) images were also taken for comparison.
Immunoblotting
The immunoblotting procedure has been previously
described [14]. Briefly, proteins were separated using
SDS-polyacrylamide gels and transferred to nitrocellu-
lose membranes. The membranes were blocked with 5%
nonfat dry milk or 5% BSA in 0.01 M PBS (pH 7.4) and
0.05% Tween-20 (TPBS) at room temperature for 1 h.
Subsequently, the membranes were incubated with pri-
mary antibodies directed against target proteins over-
night at 4°C. The final dilutions for primary antibodies
were: anti-GluR2 1:2,000; anti-ADAR2, 1:1,000; anti-
ADAR1, 1:1000). The blots were washed, incubated with
a secondary antibody conjugated to horseradish peroxi-
dase (Amersham, Arlington He i g h t s ,I L ,U S A ) ,d i l u t e d
at 1:5,000 in TPBS for 2 h, and visualized by the
enhanced chemiluminescence (ECL) method (Amer-
sham). The expression of specific proteins was quanti-
fied with the software of Quantity One (Bio-Rad
Laboratories, Hercules, CA, USA).
ADAR2 self-editing assay and Q/R editing assay
Total RNA was isolated from cultured neurons with
TRIzol reagent (Invitrogen Corporation, Carlsbad, CA,
USA) followed by digestion with RNase-free DNase I
(Roche Diagnostics Corp. Indianapolis, IN, USA) to
eliminate possible DNA contamination. First-strand
cDNA was synthesized by moloney murine leukemia
virus reverse transcriptase and Oligo dT primers (Pro-
mega Corporation, Madison, WI, USA) [40].
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tion solution containing 2× Taq Premixure buffer (Tian-
gen Biotech, Beijing, China) and 20 μMp r i m e r .T h e
PCR amplification protocol was 95°C for 5 min, followed
by 40 cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for
15 s and finished with a final extension of 72°C for 10
min. PCR primers used in this study are as follows:
ADAR2 forward, 5’-GCCAGTCAAGAAGCCCTCA-3’;
ADAR2 reverse, 5’-TGTCCAGATTGCGGTTTT-3’;
GluR2 forward, 5’-TTGAAGGGAATGAGCGTTAT-3’;
GluR2 reverse, 5’-GCCGTGTAGGAGGAGATG-3’.T h e
PCR products of ADAR2 were run on a 1% agarose gel
and visualized by the Dolphin-Scan image system. The
unedited PCR products of ADAR2 were 102 bp, and the
edited PCR products of ADAR2 were 149 bp. The edit-
ing efficiency was quantified using Dolphin-1 D software
(Wealtec, Sparks, NV, USA), and the percentage of
ADAR2 self-editing was calculated. The PCR products
of GluR2 were sequenced and analyzed for its Q/R site
editing [40].
Real-time PCR
Real-time quantitative PCR was conducted with ABI
Prism 7500 Sequence Detection System according to the
instruction of the manufacturer (Applied Biosystems,
Foster City, CA, USA). RT-PCR primers used in this
study are as follows: GluR2 forward, 5’-CCAT-
GAAAGTGGGAGGTAACTTG-3’; GluR2 reverse,
5’-AAGCCCCTGCTCGTTCAGT-3’;A D A R 2f o r w a r d ,
5’-TGTAAGCACGCGCTGTACTGT-3’;A D A R 2
reverse, 5’-GACTCGTGGTATGTGGTAGGCTTAG-3’;
b-actin forward, 5’-GATCATTGCTCCTCCTGAGC-3’;
b-actin reverse, 5’-ACTCCTGCTTGCTGATCCAC-3’.
For relative comparison of each gene, we analyzed the
Ct value of real-time PCR data with the ΔΔCt method
normalized by an endogenous control (b-actin) [62].
Plasmids and cell transfection
pcDNA6, pcDNA6-myc-ADAR2, Lentivirus-shADAR2
RNA (5’-GCAGCTGAACGAGATCAAACC-3’), Lenti-
virus-scramble RNA (5’-GATGTTGTCAACGAC-
TAGTTT-3’) and yellow fluorescence protein (YFP)
were provided by Dr. Yong Liu (Institute for Nutritional
Sciences, Shanghai, China). Cell transfection was per-
formed using a Mouse Neuron Nucleofection kit
(Amaxa, Koelh, Germany) [14]. Briefly, 2.5 × 10
6 cortical
neurons were centrifuged and resuspended in 100 μL
transfection buffer. One microgram of plasmids
(pcDNA6-myc-ADAR2, pcDNA6, YFP, lentivirus-shA-
DAR2 or Lentivirus-scramble RNA) together with one
microgram of YFP was added to the neurons; the trans-
fection was performed using an Amaxa Nucleofection
apparatus. After the transfection, cells were transferred
to cell culture dishes and grown in Neurobasal/B-27
media. The transfection efficiency was approximately
70% which was determined by YFP-positive cells.
Statistical analysis
Data were presented as means ± SEM. Differences
among treatment groups were assessed by ANOVA fol-
lowed by Student-Newman-Keuls analyses. Differences
in which p w a sl e s st h a n0 . 0 5w e r ec o n s i d e r e ds t a t i s t i -
cally significant.
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